adenosine has been researched along with Lymphoma, Mantle-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernasconi, E; Bertoni, F; Cascione, L; Dirnhofer, S; Gaudio, E; Gerlach, MM; Mascia, M; Priebe, V; Spriano, F; Stathis, A; Tarantelli, C; Targa, A; Zucca, E | 1 |
| Ayres, ML; Dennison, JB; Gandhi, V; Krett, NL; Medeiros, LJ; Neelapu, SS; Qian, J; Rosen, ST; Shanmugam, M | 1 |
| Feng, G; Gandhi, V; Krett, NL; McBrayer, SK; Qian, J; Rosen, ST; Shanmugam, M; Yarrington, M | 1 |
| Atadja, P; Balusu, R; Bhalla, K; Fiskus, W; Ganguly, S; Hembruff, SL; Marquez, VE; Mudunuru, U; Rao, R; Smith, JE; Sotomayor, E; Tao, J | 1 |
4 other study(ies) available for adenosine and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas.
Topics: Adenosine; Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Mice, SCID; Protein Kinase Inhibitors; Pyrazines; Quinolines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.
Topics: Adenosine; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Lymphoma, Mantle-Cell; Phosphorylation; Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Transcription, Genetic; Tumor Cells, Cultured | 2010 |
Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms.
Topics: 2-Chloroadenosine; Adenosine; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucosephosphate Dehydrogenase; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasm Proteins; Pentose Phosphate Pathway; RNA, Neoplasm | 2012 |
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.
Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Proliferation; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Lymphoma, Mantle-Cell; Mice; Mice, Inbred NOD; Mice, SCID; Muscle Proteins; Neoplasm Proteins; Panobinostat; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Protein Binding; RNA Interference; SKP Cullin F-Box Protein Ligases; Transcription Factors; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |